Nitric oxide synthase inhibition reduces wakefulness
- 30 November 1994
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 33 (11) , 1505-1509
- https://doi.org/10.1016/0028-3908(94)90055-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists.Circulation Research, 1993
- 5-HT1-like receptor agonists enhance wakefulnessNeuropharmacology, 1992
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991
- Localization of nitric oxide synthase indicating a neural role for nitric oxideNature, 1990
- Control of regional blood flow by endothelium-derived nitric oxide.Hypertension, 1990
- Endothelial cells metabolize NG -monomethyl-L-arginine to L-citrulline and subsequently to L-arginineBiochemical and Biophysical Research Communications, 1990
- Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phophonovalerate (D-AP5) on rat cortical slicesEuropean Journal of Pharmacology, 1988
- ALTERATIONS IN ACETYLCHOLINE SYNTHESIS AND CYCLIC NUCLEOTIDES IN MILD CEREBRAL HYPOXIAJournal of Neurochemistry, 1978
- Climbing fiber activation and 3′,5′-cyclic guanosine monophosphate (cGMP) content in cortex and deep nuclei of cerebellumBrain Research, 1976
- EEG-synchronizing effect of γ-hydroxybutyrate and 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) in relation to dopaminergic brain functionNeuropharmacology, 1975